---
category: news
title: "AI research finds a ‘compute divide’ concentrates power and accelerates inequality in the era of deep learning"
excerpt: "The analysis reviews papers accepted for publication at large AI conferences such as ACL, ICML, and NeurIPS in categories like computer vision, data mining, machine learning, and NLP."
publishedDateTime: 2020-11-11T16:26:00Z
originalUrl: "https://venturebeat.com/2020/11/11/ai-research-finds-a-compute-divide-concentrates-power-and-accelerates-inequality-in-the-era-of-deep-learning/"
webUrl: "https://venturebeat.com/2020/11/11/ai-research-finds-a-compute-divide-concentrates-power-and-accelerates-inequality-in-the-era-of-deep-learning/"
ampWebUrl: "https://venturebeat.com/2020/11/11/ai-research-finds-a-compute-divide-concentrates-power-and-accelerates-inequality-in-the-era-of-deep-learning/amp/"
cdnAmpWebUrl: "https://venturebeat-com.cdn.ampproject.org/c/s/venturebeat.com/2020/11/11/ai-research-finds-a-compute-divide-concentrates-power-and-accelerates-inequality-in-the-era-of-deep-learning/amp/"
type: article
quality: 84
heat: 94
published: true

provider:
  name: VentureBeat
  domain: venturebeat.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/venturebeat.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Machine Learning
  - AI

images:
  - url: "https://venturebeat.com/wp-content/uploads/2018/10/mit1.jpg?fit=800%2C600&strip=all"
    width: 800
    height: 600
    isCached: true

related:
  - title: "BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update"
    excerpt: "Complete NDA submission for BXCL501 for the acute treatment of agitation in patients with schizophrenia and bipolar disorders on track for Q1 2021 TRANQUILITY and RELEASE studies are on track; Preparing to initiate a Phase 2 trial with BXCL501 in patients with agitation associated with delirium Encouraging data from the two ongoing combination trials of BXCL701 and KEYTRUDA (R) was presented at the Society for Immunotherapy of Cancer's 35 th Anniversary Annual Meeting (\"SITC\") Strong cash position of $233 million to fund key milestones well into 2022 Company to host conference call today at 8:30 a."
    publishedDateTime: 2020-11-12T07:23:00Z
    webUrl: "https://www.marketwatch.com/press-release/bioxcel-therapeutics-reports-third-quarter-2020-financial-results-and-provides-business-update-2020-11-12-71842344"
    type: article
    provider:
      name: MarketWatch
      domain: marketwatch.com
    quality: 42
    images:
      - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
        width: 1200
        height: 630
        isCached: true

secured: "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;OaJH7rbQV2kI4ClT6j/HYg=="
---

